These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 30506501)
1. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience. Haider SA; Lim S; Kalkanis SN; Lee IY J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501 [TBL] [Abstract][Full Text] [Related]
2. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review. Coburger J; Wirtz CR J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293 [TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883 [TBL] [Abstract][Full Text] [Related]
4. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781 [TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas. Chohan MO; Berger MS J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823 [TBL] [Abstract][Full Text] [Related]
6. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963 [TBL] [Abstract][Full Text] [Related]
7. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review. Broekx S; Weyns F; De Vleeschouwer S Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151 [TBL] [Abstract][Full Text] [Related]
8. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience. Chan DTM; Yi-Pin Sonia H; Poon WS Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780 [TBL] [Abstract][Full Text] [Related]
9. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review. Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964 [TBL] [Abstract][Full Text] [Related]
10. Following the light in glioma surgery: a comparison of sodium fluorescein and 5-aminolevulinic acid as surgical adjuncts in glioma resection. Navarro-Bonnet J; Suarez-Meade P; Brown DA; Chaichana KL; Quinones-Hinojosa A J Neurosurg Sci; 2019 Dec; 63(6):633-647. PubMed ID: 31961116 [TBL] [Abstract][Full Text] [Related]
13. The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review. Mansouri A; Mansouri S; Hachem LD; Klironomos G; Vogelbaum MA; Bernstein M; Zadeh G Cancer; 2016 Aug; 122(16):2469-78. PubMed ID: 27183272 [TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up. Strickland BA; Wedemeyer M; Ruzevick J; Micko A; Shahrestani S; Daneshmand S; Shiroishi MS; Hwang DH; Attenello F; Chen T; Zada G J Neurosurg; 2022 Nov; 137(5):1378-1386. PubMed ID: 35303704 [TBL] [Abstract][Full Text] [Related]
15. Enhanced resection of primary high-grade gliomas using a combination of intraoperative magnetic resonance imaging and intraoperative fluorescence (5-aminolevulinic acid): A single-centre experience. Sharma V; Kedia R; Narang KS; Jha AN Neurol India; 2018; 66(3):747-752. PubMed ID: 29766937 [TBL] [Abstract][Full Text] [Related]
16. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery. Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489 [TBL] [Abstract][Full Text] [Related]
17. Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note. Morshed RA; Han SJ; Lau D; Berger MS J Neurosurg; 2018 May; 128(5):1448-1453. PubMed ID: 28665248 [TBL] [Abstract][Full Text] [Related]
18. 5-ALA and FDA approval for glioma surgery. Hadjipanayis CG; Stummer W J Neurooncol; 2019 Feb; 141(3):479-486. PubMed ID: 30644008 [TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid-Guided Surgery: A Systematic Review and Meta-Analysis. Gandhi S; Tayebi Meybodi A; Belykh E; Cavallo C; Zhao X; Syed MP; Borba Moreira L; Lawton MT; Nakaji P; Preul MC Front Oncol; 2019; 9():620. PubMed ID: 31380272 [No Abstract] [Full Text] [Related]
20. The effectiveness and cost-effectiveness of intraoperative imaging in high-grade glioma resection; a comparative review of intraoperative ALA, fluorescein, ultrasound and MRI. Eljamel MS; Mahboob SO Photodiagnosis Photodyn Ther; 2016 Dec; 16():35-43. PubMed ID: 27491856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]